Islet cell transplantation is a promising therapy for people with type 1 diabetes, but it requires a regime of powerful immunosuppressive drugs so the immune system won’t reject the insulin-producing islets. The drugs raise the risk of infections and cancer and are toxic to the islets themselves. Researchers have developed a new technique that eliminated the need for these drugs. The strategy is a potential therapy for human islet cell transplantation.